Medpace

MEDPNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$17.422 B

$624.20 +1.94%

Close of 21 Sept 2026

Revenue

$2.53B

#1014 by revenue

Earnings

$451.1M

#657 by earnings

Shares outstanding

27,911,655

Latest filing cover page

P/E ratio

38.6

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#1IqviaIQV$44.4B
#2IncyteINCY$25.3B
#3MedpaceMEDP$17.4B
#4Charles River Laboratories InternationalCRL$13.3B
#5IconICLR$13.0B

What if Medpace were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,084,638

Per share 1,738× higher

Bitcoin $1.72T

$61,615.97

Per share 98.7× higher

Nvidia $5.48T

$196,328.67

Per share 315× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Medpace are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.